Clopidogrel
hideClopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix, by Sun Pharmaceuticals under the trade name Clopilet, by Ranbaxy Laboratories under the trade name Ceruvin. It works by irreversibly inhibiting a receptor called P2Y12. Adverse effects include hemorrhage.
For more information about Clopidogrel, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with plavix
Drug ads ineffective for boosting sales, could cost taxpayers: study
Nov 23, 2009 |
not rated yet |
0
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.
FDA says heartburn drugs can interfere with Plavix
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
(AP) -- Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack ...
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
(PhysOrg.com) -- Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked ...
Medco plans to compare Plavix, Effient in study
Medicine & Health / Medications
Oct 20, 2009 |
not rated yet |
0
(AP) -- Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with the newer Effient.
Newer Anti-Clotting Medication Found to Be More Effective
Medicine & Health / Medications
Aug 30, 2009 |
4 / 5 (2) |
0
(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the ...
Study shows experimental drug cuts stroke risk
Medicine & Health / Medications
Aug 30, 2009 |
5 / 5 (1) |
0
(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.
Researchers identify gene variant linked to effectiveness of plavix
Aug 25, 2009 |
not rated yet |
0
Researchers at the University of Maryland School of Medicine have identified a common gene variant carried by as many as a third of the general population that is believed to play a major role in determining why people do ...
FDA clears Eli Lilly's blood thinner Effient
Medicine & Health / Medications
Jul 10, 2009 |
not rated yet |
0
(AP) -- The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
How life-threatening blood clots take hold
Apr 16, 2009 |
not rated yet |
0
When plaques coating blood vessel walls rupture and expose collagen, platelets spring into action to form a blood clot at the damaged site. Now, a new report in the April 17th issue of the journal Cell, a Cell Press public ...
Study: Plavix plus aspirin helps prevent strokes
Mar 31, 2009 |
4 / 5 (1) |
0
(AP) -- Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday.
